Perspectives of caregivers of older adults with acute myeloid leukemia during initial hypomethylating agents and venetoclax chemotherapy-Reference-Cited by-同舟云学术

Perspectives of caregivers of older adults with acute myeloid leukemia during initial hypomethylating agents and venetoclax chemotherapy

Published:2023-01 Issue:1 Volume:31 Page:
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Tan Kelly R.,Chan Ya-Ning,Iadonisi Katie,Poor Elissa,Betancur Stephanie,Jung Ahrang,Sagester Kathryn,Coppola Susan,Pergolotti Mackenzi,Kent Erin E.,Schwartz Todd,Richardson Daniel,Bryant Ashley Leak

Funder

National Cancer Institute

American Cancer Society

Sigma Theta Tau International

School of Nursing, University of North Carolina at Chapel Hill

National Institute of Nursing Research

Rita and Alex Hillman Foundation

Jonas Philanthropies

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00520-022-07565-7.pdf

Reference26 articles.

1. DiNardo CD, Pratz K, Pullarkat V et al (2019) Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia. Blood 133(1):7–17

2. Lachowiez CA, Loghavi S, Kadia TM, Daver N, Borthakur G, Pemmaraju N, Naqvi K, Alvarado Y, Yilmaz M, Short N, Ohanian M, Pierce SR, Patel KP, Qiao W, Ning J, Sasaki K, Takahashi K, Jabbour E, Andreeff M, Ravandi F, … DiNardo CD (2020) Outcomes of older patients with NPM1-mutated AML: current treatments and the promise of venetoclax-based regimens. Blood Adv, 4(7), 1311–1320. https://doi.org/10.1182/bloodadvances.2019001267

3. Wei AH, Montesinos P, Ivanov V, DiNardo CD, Novak J, Laribi K, Kim I, Stevens DA, Fiedler W, Pagoni M, Samoilova O, Hu Y, Anagnostopoulos A, Bergeron J, Hou JZ, Murthy V, Yamauchi T, McDonald A, Chyla B, Gopalakrishnan S, … Panayiotidis P (2020). Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial. Blood, 135(24), 2137–2145. https://doi.org/10.1182/blood.2020004856

4. Winters AC, Gutman JA, Purev E, Nakic M, Tobin J, Chase S, Kaiser J, Lyle L, Boggs C, Halsema K, Schowinsky JT, Rosser J, Ewalt MD, Siegele B, Rana V, Schuster S, Abbott D, Stevens BM, Jordan CT, Smith C, … Pollyea DA (2019). Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia. Blood Adv, 3(20), 2911–2919. https://doi.org/10.1182/bloodadvances.2019000243

5. Dionne-Odom JN, Currie ER, Johnston EE, Rosenberg AR (2019) Supporting family caregivers of adult and pediatric persons with leukemia. Semin Oncol Nurs 35(6):150954. https://doi.org/10.1016/j.soncn.2019.150954

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the role of the oncologist in promoting shared decision making during treatment planning for older adults with acute myeloid leukemia;Journal of Geriatric Oncology;2024-06

2. “A strong reason why I enjoy coming to work”: Clinician acceptability of a palliative and supportive care intervention (PACT) for older adults with acute myeloid leukemia and their care partners;Journal of Geriatric Oncology;2024-04

3. Time to define and refine maintenance strategies in acute myeloid leukaemia;The Lancet Haematology;2024-04

4. Fear of cancer recurrence and associated factors in family caregivers of patients with hematologic malignancy receiving chemotherapy: A latent profile analysis;Asia-Pacific Journal of Oncology Nursing;2024-04